AI in drug discovery

News

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

Insilico Medicine has teamed up with SK Biopharmaceuticals on a wide-ranging, $2.5bn partnership to use AI to find neuroimmune drug candidates.

News

MSD steps out with Protillion in $510m+ AI shindig

MSD has teamed up with Protillion Bio in a deal worth more than $510m, focusing on using the AI start-up's lab-in-the-loop platform for drug discovery

News

Anthropic puts life sciences at heart of new AI model

Anthropic has released Claude Fable 5, trumpeting its R&D credentials, but has faced a backlash over "safeguards" built into the model.

News

Meet Dalton, a new AI-powered drug discovery platform

Just a few months after emerging from stealth, the UK's DaltonTx has launched its AI in drug discovery platform and revealed its first client.

News

Zuckerberg, Chan's Biohub launches protein 'world model'

Chan Zuckberg Initiative-backed Biohub has made what it says is an AI-powered "world model" of protein biology available freely to researchers.

News

OpenBind unveils its first AI model for drug discovery

A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

MSD steps out with Protillion in $510m+ AI shindig

Anthropic puts life sciences at heart of new AI model

Meet Dalton, a new AI-powered drug discovery platform

Zuckerberg, Chan's Biohub launches protein 'world model'

OpenBind unveils its first AI model for drug discovery

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

AI in drug discovery

Editor's Picks